NCT01400802View on ClinicalTrials.gov

Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Mixture Listro Mix 75/25® and Humalog Mix75/25 ® in Healthy Subjects

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

June 30, 2012

Conditions
Bioequivalence in Healthy Subjects
Interventions
BIOLOGICAL

Insulin Lispro

Dosage form- Subcutaneous Injection

Trial Locations (1)

91911

Profil Institute for Clinical Research, Inc., San Diego

Sponsors

Lead Sponsor

Wockhardt
All Listed Sponsors
lead

Wockhardt

INDUSTRY